Accueil / Tag Archives: Oncology

Tag Archives: Oncology

Advaxis to Present at 2017 BIO International Convention

Friday, June 16th 2017 at 12:00pm UTC PRINCETON, N.J.–(BUSINESS WIRE)– Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company developing cancer immunotherapies, today announced that Ranya Dajani, Vice President, Business Development, will present a company overview at the 2017 Biotechnology Innovation Organization’s (BIO) International Convention in San Diego, CA. Event: 2017 …

Plus »

ADC Therapeutics Presents First Clinical Data from its Novel Antibody-Drug Conjugate ADCT-402 at the International Conference on Malignant Lymphoma

Friday, June 16th 2017 at 10:03pm UTC – First clinical data of ADCT-402 demonstrate encouraging antitumor activity in relapsed or refractory non-Hodgkin’s lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE)– ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, …

Plus »

Precipio and Transgenomic Announce Experts from Yale and Harvard Joining New Scientific Advisory Board to Support Merged Company’s Growth Initiatives

Friday, June 16th 2017 at 12:00pm UTC Distinguished Experts in Disease Diagnosis and Diagnostics Technology Bring World Class Scientific Acumen and Insight to Help Guide the New Merged Company’s Expansion and Growth Other Recent Pre-Merger Developments Include EPO Decision to Grant Patent Protection in Europe for Transgenomic’s Multiplexed ICE COLD-PCR …

Plus »

SCORR Marketing Adds Three Health Science Marketing Experts

Thursday, June 15th 2017 at 7:04pm UTC KEARNEY, Neb.–(BUSINESS WIRE)– SCORR Marketing, a global health science marketing and communications firm, announces the addition of three employees with health science marketing expertise, including Lea LaFerla, vice president of marketing services; Edlyn Tobias, marketing technology manager; and James Wang, associate director of …

Plus »

Extended Follow-Up Data Evaluating Opdivo (nivolumab) Shows Durable Response in Adult Patients with Relapsed or Progressed Classical Hodgkin Lymphoma

Friday, June 16th 2017 at 10:58am UTC Results show overall response rates of 65% or greater with median follow-up of at least 16 months, regardless of prior brentuximab vedotin therapies PRINCETON, N.J.–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) today announced extended follow-up data in which Opdivo (nivolumab) demonstrated responses in adult …

Plus »

Dr. Yasir Al-Wakeel Joins Neon Therapeutics as Chief Financial Officer

Friday, June 16th 2017 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat cancer, today announced that Yasir Al-Wakeel will join the company as chief financial officer beginning July 5, 2017. Dr. Al-Wakeel replaces Daniella Beckman, who has …

Plus »

Checkmate Pharmaceuticals Secures $27 Million Series B Preferred Financing and Appoints Karen Brennan as Chief Operating Officer

Thursday, June 15th 2017 at 8:44pm UTC Funding and Expansion of Management Team Support Further Clinical Development of Checkmate’s TLR9 Agonist, CMP-001 CAMBRIDGE, Mass.–(BUSINESS WIRE)– Checkmate Pharmaceuticals (Checkmate), a clinical-stage biopharmaceutical company focused on developing novel approaches for cancer immunotherapy, announced that it has completed a $27 million Series B …

Plus »

Merck Becomes Member of the Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium (Paris)

Thursday, June 15th 2017 at 10:00am UTC PARIS & DARMSTADT, Germany–(BUSINESS WIRE)– Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium proudly announces today that Merck, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, becomes a member of the WIN Consortium. WIN is a network of …

Plus »

Merck devient membre du Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium (Paris)

Thursday, June 15th 2017 at 10:00am UTC PARIS & DARMSTADT, Allemagne–(BUSINESS WIRE)– Le Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium est fier d’annoncer que Merck, dont les activités biopharmaceutiques sont exercées sous la dénomination EMD Serono aux États-Unis et au Canada, devient membre de WIN. Le consortium WIN …

Plus »

Celgene presenta en ASCO 2017 datos actualizados de un ensayo fase I Enasidenib (IDHIFA®) vía oral demuestra respuestas completas y duración de las respuestas en pacientes con Leucemia Mieloide Aguda…

Thursday, June 15th 2017 at 1:51pm UTC La tasa de respuesta global (TRG) fue del 40,3 % con una duración media de la respuesta de 5,8 meses. La tasa de respuesta completa (RC) fue del 19,3 % con una duración media de la respuesta de 8,8 meses en pacientes con …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...